Laurion Capital Management LP - BRIDGEBIO PHARMA INC ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$14,494,226
+23.1%
19,100,0000.0%0.09%
+33.3%
Q2 2023$11,771,71219,100,0000.07%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Diameter Capital Partners LP 52,257,000$39,745,1068.72%
Context Capital Management, LLC 32,083$24,0521.93%
BRAIDWELL LP 67,294,000$50,470,5001.60%
DeepCurrents Investment Group LLC 17,855,000$13,514,0560.59%
Aequim Alternative Investments LP 20,000,000$15,000,0000.57%
ADVENT CAPITAL MANAGEMENT /DE/ 29,488,000$22,116,0000.51%
SILVERBACK ASSET MANAGEMENT LLC 5,000,000$3,750,3750.51%
ARISTEIA CAPITAL, L.L.C. 25,280,000$18,960,0000.51%
SSI INVESTMENT MANAGEMENT LLC 8,217,000$6,121,6650.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,604,000$3,430,5200.49%
View complete list of BRIDGEBIO PHARMA INC shareholders